Speaker illustration

Doctor Satoshi Yamashita

Hamamatsu University School of Medicine, Hamamatsu (Japan)

Relevance of serum globotriaosylsphingosine concentration (lyso-Gb3) for screening of Fabry disease in patients with left ventricular hypertrophy

Event: ESC Congress 2017

Topic: Cardiomyopathies

Session: Cardiomyopathy in Fabry disease

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb